HPB Surgery
Volume 2008 (2008), Article ID 839503, 8 pages
doi:10.1155/2008/839503
Review Article

Controversies in the Management of Borderline Resectable Proximal Pancreatic Adenocarcinoma with Vascular Involvement

The Department of Hepatopancreaticobiliary and Liver Transplant Surgery, King's College Hospital, Denmark Hill, London SE5 9RS, UK

Received 6 November 2007; Revised 28 July 2008; Accepted 18 December 2008

Academic Editor: Richard Charnley

Copyright © 2008 Olga N. Tucker and Mohamed Rela. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Matsuno, S. Egawa, S. Fukuyama, et al., “Pancreatic cancer registry in Japan: 20 years of experience,” Pancreas, vol. 28, no. 3, pp. 219–230, 2004. View at Publisher · View at Google Scholar
  2. “National Comprehensive Cancer Network Practice Guidelines in Oncology for Pancreatic Adenocarcinoma—v.1,” November 2008.
  3. G. R. Varadhachary, E. P. Tamm, J. L. Abbruzzese, et al., “Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy,” Annals of Surgical Oncology, vol. 13, no. 8, pp. 1035–1046, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. G. M. Fuhrman, C. Charnsangavej, J. L. Abbruzzese, et al., “Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms,” The American Journal of Surgery, vol. 167, no. 1, pp. 104–113, 1994. View at Publisher · View at Google Scholar
  5. M. Talamonti, “Borderline resectable pancreatic cancer: a new classification for an old challenge,” Annals of Surgical Oncology, vol. 13, no. 8, pp. 1019–1020, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. K. Takeshita, S. Furui, and K. Takada, “Multidetector row helical CT of the pancreas: value of three-dimensional images, two-dimensional reformations, and contrast-enhanced multiphasic imaging,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 9, no. 5, pp. 576–582, 2002. View at Publisher · View at Google Scholar · View at PubMed
  7. E. M. Merkle, D. T. Boll, and S. Fenchel, “Helical computed tomography of the pancreas: potential impact of higher concentrated contrast agents and multidetector technology,” Journal of Computer Assisted Tomography, vol. 27, pp. S17–S22, 2003.
  8. W. Schima, A. Ba-Ssalamah, C. Köiblinger, C. Kulinna-Cosentini, A. Puespoek, and P. Götzinger, “Pancreatic adenocarcinoma,” European Radiology, vol. 17, no. 3, pp. 638–649, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. P. F. Saldinger, M. Reilly, K. Reynolds, et al., “Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?,” Journal of Gastrointestinal Surgery, vol. 4, no. 3, pp. 233–239, 2000.
  10. R. J. Bold, C. Charnsangavej, K. R. Cleary, et al., “Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis,” Journal of Gastrointestinal Surgery, vol. 3, no. 3, pp. 233–243, 1999. View at Publisher · View at Google Scholar
  11. E. F. Yekebas, D. Bogoevski, G. Cataldegirmen, et al., “En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients,” Annals of Surgery, vol. 247, no. 2, pp. 300–309, 2008. View at Publisher · View at Google Scholar · View at PubMed
  12. P. C. Freeny, “Pancreatic carcinoma: imaging update 2001,” Digestive Diseases, vol. 19, no. 1, pp. 37–46, 2001. View at Publisher · View at Google Scholar
  13. C. Catalano, A. Laghi, F. Fraioli, et al., “Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability,” European Radiology, vol. 13, no. 1, pp. 149–156, 2003.
  14. P. W. T. Pisters, J. E. Lee, J. N. Vauthey, C. Charnsangavej, and D. B. Evans, “Laparoscopy in the staging of pancreatic cancer,” British Journal of Surgery, vol. 88, no. 3, pp. 325–337, 2001. View at Publisher · View at Google Scholar · View at PubMed
  15. K. C. Conlon, E. Dougherty, D. S. Klimstra, D. G. Coit, A. D. M. Turnbull, and M. F. Brennan, “The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy,” Annals of Surgery, vol. 223, no. 2, pp. 134–140, 1996. View at Publisher · View at Google Scholar
  16. J. M. Catheline, R. Turner, N. Rizk, C. Barrat, and G. Champault, “The use of diagnostic laparoscopy supported by laparoscopic ultrasonography in the assessment of pancreatic cancer,” Surgical Endoscopy, vol. 13, no. 3, pp. 239–245, 1999. View at Publisher · View at Google Scholar
  17. K. R. Reddy, J. Levi, A. Livingstone, et al., “Experience with staging laparoscopy in pancreatic malignancy,” Gastrointestinal Endoscopy, vol. 49, no. 4, pp. 498–503, 1999. View at Publisher · View at Google Scholar
  18. R. E. Jimenez, A. L. Warshaw, D. W. Rattner, C. G. Willett, D. McGrath, and C. Fernández-del Castillo, “Impact of laparoscopic staging in the treatment of pancreatic cancer,” Archives of Surgery, vol. 135, no. 4, pp. 409–415, 2000. View at Publisher · View at Google Scholar
  19. T. Yoshida, T. Matsumoto, Y. Morii, et al., “Staging with helical computed tomography and laparoscopy in pancreatic head cancer,” Hepato-Gastroenterology, vol. 49, no. 47, pp. 1428–1431, 2002.
  20. C. Fernández-del Castillo, D. W. Rattner, and A. L. Warshaw, “Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer,” British Journal of Surgery, vol. 82, no. 8, pp. 1127–1129, 1995. View at Publisher · View at Google Scholar
  21. M. P. Callery, S. M. Strasberg, G. M. Doherty, N. J. Soper, and J. A. Norton, “Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy,” Journal of the American College of Surgeons, vol. 185, no. 1, pp. 33–39, 1997. View at Publisher · View at Google Scholar
  22. O. N. Tucker and K. C. Conlon, “Laparoscopic staging,” in Pancreatic Cancer, D. D. von Hoff, D. B. Evans, and R. H. Hruban, Eds., pp. 207–222, Jones and Bartlett, Sudbury, Mass, USA, 2005.
  23. T. G. John, J. D. Greig, D. C. Carter, and O. J. Garden, “Carcinoma of the pancreatic head and periampullary region: tumor staging with laparoscopy and laparoscopic ultrasonography,” Annals of Surgery, vol. 221, no. 2, pp. 156–164, 1995. View at Publisher · View at Google Scholar
  24. W. A. Bemelman, L. T. de Wit, O. M. van Delden, et al., “Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region,” British Journal of Surgery, vol. 82, no. 6, pp. 820–824, 1995. View at Publisher · View at Google Scholar
  25. M. P. Callery, S. M. Strasberg, G. M. Doherty, N. J. Soper, and J. A. Norton, “Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy,” Journal of the American College of Surgeons, vol. 185, no. 1, pp. 33–39, 1997. View at Publisher · View at Google Scholar
  26. R. E. Jimenez, A. L. Warshaw, and C. Fernández-del Castillo, “Laparoscopy and peritoneal cytology in the staging of pancreatic cancer,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 7, no. 1, pp. 15–20, 2000. View at Publisher · View at Google Scholar
  27. C. Fernández-del Castillo and A. L. Warshaw, “Pancreatic cancer. Laparoscopic staging and peritoneal cytology,” Surgical Oncology Clinics of North America, vol. 7, no. 1, pp. 135–142, 1998.
  28. N. B. Merchant, K. C. Conlon, P. Saigo, E. Dougherty, and M. F. Brennan, “Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma,” Journal of the American College of Surgeons, vol. 188, no. 4, pp. 421–426, 1999. View at Publisher · View at Google Scholar
  29. P. P. Schachter, Y. Avni, M. Shimonov, G. Gvirtz, A. Rosen, and A. Czerniak, “The impact of laparoscopy and laparoscopic ultrasonography on the management of pancreatic cancer,” Archives of Surgery, vol. 135, no. 11, pp. 1303–1307, 2000. View at Publisher · View at Google Scholar
  30. E. A. Minnard, K. C. Conlon, A. Hoos, E. C. Dougherty, L. E. Hann, and M. F. Brennan, “Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer,” Annals of Surgery, vol. 228, no. 2, pp. 182–187, 1998. View at Publisher · View at Google Scholar
  31. T. G. John, A. Wright, P. L. Allan, et al., “Laparoscopy with laparoscopic ultrasonography in the TNM staging of pancreatic carcinoma,” World Journal of Surgery, vol. 23, no. 9, pp. 870–881, 1999. View at Publisher · View at Google Scholar
  32. E. A. Minnard, K. C. Conlon, A. Hoos, E. C. Dougherty, L. E. Hann, and M. F. Brennan, “Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer,” Annals of Surgery, vol. 228, no. 2, pp. 182–187, 1998. View at Publisher · View at Google Scholar
  33. A. Pietrabissa, D. Caramella, G. Di Candio, et al., “Laparoscopy and laparoscopic ultrasonography for staging pancreatic cancer: critical appraisal,” World Journal of Surgery, vol. 23, no. 10, pp. 998–1003, 1999. View at Publisher · View at Google Scholar
  34. B. Rumstadt, M. Schwab, K. Schuster, E. Hagmüller, and M. Trede, “The role of laparoscopy in the preoperative staging of pancreatic carcinoma,” Journal of Gastrointestinal Surgery, vol. 1, no. 3, pp. 245–250, 1997. View at Publisher · View at Google Scholar
  35. S. M. Singh, W. P. Longmire, Jr., and H. A. Reber, “Surgical palliation for pancreatic cancer: the UCLA experience,” Annals of Surgery, vol. 212, no. 2, pp. 132–139, 1990. View at Publisher · View at Google Scholar
  36. A. L. Warshaw and R. S. Swanson, “Pancreatic cancer in 1988: possibilities and probabilities,” Annals of Surgery, vol. 208, no. 5, pp. 541–553, 1988. View at Publisher · View at Google Scholar
  37. M. G. Sarr and J. L. Cameron, “Surgical palliation of unresectable carcinoma of the pancreas,” World Journal of Surgery, vol. 8, no. 6, pp. 906–918, 1984. View at Publisher · View at Google Scholar
  38. P. D. de Rooij, M. F. Brennan, and A. Rogatko, “Evaluation of palliative surgical procedures in unresectable pancreatic cancer,” British Journal of Surgery, vol. 78, no. 9, pp. 1053–1058, 1991. View at Publisher · View at Google Scholar
  39. N. J. Espat, M. F. Brennan, and K. C. Conlon, “Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass,” Journal of the American College of Surgeons, vol. 188, no. 6, pp. 649–657, 1999. View at Publisher · View at Google Scholar
  40. A. Nakao, S. Takeda, S. Inoue, et al., “Indications and techniques of extended resection for pancreatic cancer,” World Journal of Surgery, vol. 30, no. 6, pp. 976–982, 2006. View at Publisher · View at Google Scholar · View at PubMed
  41. E. Tezel, T. Kaneko, S. Takeda, S. Inoue, T. Nagasaka, and A. Nakao, “Intraportal endovascular ultrasound for portal vein resection in pancreatic carcinoma,” Hepato-Gastroenterology, vol. 52, no. 61, pp. 237–242, 2005.
  42. C. H. Fang, X. W. Chen, and B. L. Ju, “Value of magnetic resonance angiography combined with magnetic resonance cholangiopancreatography on diagnosis for patients with carcinoma of head of pancreas,” Zhonghua Wai Ke Za Zhi, vol. 43, no. 21, pp. 1379–1382, 2005 (Chinese).
  43. L. Zhong, L. Li, and Q.-Y. Yao, “Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques,” World Journal of Gastroenterology, vol. 11, no. 24, pp. 3756–3761, 2005.
  44. K. Yasuda, H. Mukai, S. Fujimoto, M. Nakajima, and K. Kawai, “The diagnosis of pancreatic cancer by endoscopic ultrasonography,” Gastrointestinal Endoscopy, vol. 34, no. 1, pp. 1–8, 1988. View at Publisher · View at Google Scholar
  45. N. C. Balci and R. C. Semelka, “Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma,” European Journal of Radiology, vol. 38, no. 2, pp. 105–112, 2001. View at Publisher · View at Google Scholar
  46. S. L. Brandwein, J. J. Farrell, B. A. Centeno, and W. R. Brugge, “Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS,” Gastrointestinal Endoscopy, vol. 53, no. 7, pp. 722–727, 2001. View at Publisher · View at Google Scholar · View at PubMed
  47. S. Kahl, B. Glasbrenner, S. Zimmermann, and P. Malfertheiner, “Endoscopic ultrasound in pancreatic diseases,” Digestive Diseases, vol. 20, no. 2, pp. 120–126, 2002. View at Publisher · View at Google Scholar · View at PubMed
  48. I. F. Yusoff, R. M. Mendelson, S. E. J. Edmunds, et al., “Preoperative assessment of pancreatic malignancy using endoscopic ultrasound,” Abdominal Imaging, vol. 28, no. 4, pp. 556–562, 2003. View at Publisher · View at Google Scholar
  49. Y. Wang, J. Gao, Z. Li, Z. Jin, Y. Gong, and X. Man, “Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas,” International Journal of Cancer, vol. 121, no. 12, pp. 2716–2722, 2007. View at Publisher · View at Google Scholar · View at PubMed
  50. N. S. Awadallah, K. R. Shroyer, D. A. Langer, et al., “Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct,” Pancreas, vol. 36, no. 2, pp. 200–206, 2008.
  51. N. A. Ahmad, J. D. Lewis, E. S. Siegelman, E. F. Rosato, G. G. Ginsberg, and M. L. Kochman, “Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma,” The American Journal of Gastroenterology, vol. 95, no. 8, pp. 1926–1931, 2000. View at Publisher · View at Google Scholar
  52. L. Buscall, P. Pages, P. Berthelemy, G. Fourtanier, J. Frexinos, and J. Escourrou, “Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis,” Gastrointestinal Endoscopy, vol. 50, no. 1, pp. 34–40, 1999. View at Publisher · View at Google Scholar
  53. F. G. Gress, R. H. Hawes, T. J. Savides, et al., “Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience,” Gastrointestinal Endoscopy, vol. 50, no. 6, pp. 786–791, 1999. View at Publisher · View at Google Scholar
  54. M. Cahn, K. Chang, P. Nguyen, and J. Butler, “Impact of endoscopic ultrasound with fine-needle aspiration on the surgical management of pancreatic cancer,” The American Journal of Surgery, vol. 172, no. 5, pp. 470–472, 1996. View at Publisher · View at Google Scholar
  55. C. P. Raut, A. M. Grau, G. A. Staerkel, et al., “Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer,” Journal of Gastrointestinal Surgery, vol. 7, no. 1, pp. 118–128, 2003. View at Publisher · View at Google Scholar
  56. A. Nakao and T. Kaneko, “Intravascular ultrasonography for assessment of portal vein invasion by pancreatic carcinoma,” World Journal of Surgery, vol. 23, no. 9, pp. 892–895, 1999. View at Publisher · View at Google Scholar
  57. A. Nakao, S. Takeda, M. Sakai, et al., “Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection,” Pancreas, vol. 28, no. 3, pp. 289–292, 2004. View at Publisher · View at Google Scholar
  58. H. Riediger, F. Makowiec, E. Fischer, U. Adam, and U. T. Hopt, “Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection,” Journal of Gastrointestinal Surgery, vol. 10, no. 8, pp. 1106–1115, 2006. View at Publisher · View at Google Scholar · View at PubMed
  59. K. D. Lillemoe, J. L. Cameron, C. J. Yeo, et al., “Pancreaticoduodenectomy: does it have a role in the palliation of pancreatic cancer?,” Annals of Surgery, vol. 223, no. 6, pp. 718–728, 1996. View at Publisher · View at Google Scholar
  60. R. J. Geer and M. F. Brennan, “Prognostic indicators for survival after resection of pancreatic adenocarcinoma,” The American Journal of Surgery, vol. 165, no. 1, pp. 68–73, 1993. View at Publisher · View at Google Scholar
  61. J. G. Fortner, “Regional resection of cancer of the pancreas: a new surgical approach,” Surgery, vol. 73, no. 2, pp. 307–320, 1973.
  62. Y. Nimura, “Extended surgery in bilio-pancreatic cancer: the Japanese experience,” Seminars in Oncology, vol. 29, no. 6, pp. 17–22, 2002. View at Publisher · View at Google Scholar · View at PubMed
  63. C. J. Yeo, J. L. Cameron, T. A. Sohn, et al., “Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes,” Annals of Surgery, vol. 226, no. 3, pp. 248–260, 1997. View at Publisher · View at Google Scholar
  64. G. M. Fuhrman, S. D. Leach, C. A. Staley, et al., “Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence,” Annals of Surgery, vol. 223, no. 2, pp. 154–162, 1996. View at Publisher · View at Google Scholar
  65. M. Hartel, M. Niedergethmann, M. Farag-Soliman, et al., “Benefit of venous resection for ductal adenocarcinoma of the pancreatic head,” European Journal of Surgery, vol. 168, no. 12, pp. 707–712, 2002. View at Publisher · View at Google Scholar
  66. N. Carrère, A. Sauvanet, D. Goere, et al., “Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head,” World Journal of Surgery, vol. 30, no. 8, pp. 1526–1535, 2006. View at Publisher · View at Google Scholar · View at PubMed
  67. L. E. Harrison, D. S. Klimstra, and M. F. Brennan, “Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection?,” Annals of Surgery, vol. 224, no. 3, pp. 342–349, 1996. View at Publisher · View at Google Scholar
  68. S. Fukuda, E. Oussoultzoglou, P. Bachellier, et al., “Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma,” Archives of Surgery, vol. 142, no. 2, pp. 172–179, 2007. View at Publisher · View at Google Scholar · View at PubMed
  69. P. Bachellier, H. Nakano, E. Oussoultzoglou, et al., “Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?,” The American Journal of Surgery, vol. 182, no. 2, pp. 120–129, 2001. View at Publisher · View at Google Scholar
  70. R. C. van Geenen, F. J. ten Kate, L. T. de Wit, T. M. van Gulik, H. Obertop, and D. J. Gouma, “Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy,” Surgery, vol. 129, no. 2, pp. 158–163, 2001. View at Publisher · View at Google Scholar · View at PubMed
  71. M. Al-Haddad, J. K. Martin, J. Nguyen, et al., “Vascular resection and reconstruction for pancreatic malignancy: a single center survival study,” Journal of Gastrointestinal Surgery, vol. 11, no. 9, pp. 1168–1174, 2007. View at Publisher · View at Google Scholar · View at PubMed
  72. J. H. Allema, M. E. Reinders, T. M. van Gulik, et al., “Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head,” British Journal of Surgery, vol. 81, no. 11, pp. 1642–1646, 1994. View at Publisher · View at Google Scholar
  73. J. Baulieux, M. Adham, E. Oussoultzoglou, et al., “Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?,” Chirurgie, vol. 123, no. 5, pp. 438–444, 1998 (French). View at Publisher · View at Google Scholar
  74. B. Li, F.-Z. Chen, X.-H. Ge, et al., “Pancreatoduodenectomy with vascular reconstruction in treating carcinoma of the pancreatic head,” Hepatobiliary and Pancreatic Diseases International, vol. 3, no. 4, pp. 612–615, 2004.
  75. J. D. Roder, H. J. Stein, and J. R. Siewert, “Carcinoma of the periampullary region: who benefits from portal vein resection?,” The American Journal of Surgery, vol. 171, no. 1, pp. 170–174, 1996. View at Publisher · View at Google Scholar
  76. J. F. Tseng, C. P. Raut, J. E. Lee, et al., “Pancreaticoduodenectomy with vascular resection: margin status and survival duration,” Journal of Gastrointestinal Surgery, vol. 8, no. 8, pp. 935–950, 2004. View at Publisher · View at Google Scholar · View at PubMed
  77. G.-W. Zhou, W.-D. Wu, W.-D. Xiao, H.-W. Li, and C.-H. Peng, “Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases,” Hepatobiliary and Pancreatic Diseases International, vol. 4, no. 1, pp. 130–134, 2005.
  78. T. Nakagohri, T. Kinoshita, M. Konishi, K. Inoue, and S. Takahashi, “Survival benefits of portal vein resection for pancreatic cancer,” The American Journal of Surgery, vol. 186, no. 2, pp. 149–153, 2003. View at Publisher · View at Google Scholar
  79. R. W. Marsh and T. George, “Rationale and appropriate use of chemotherapy and radiotherapy for pancreatic ductal adenocarcinoma,” Current Gastroenterology Reports, vol. 8, no. 2, pp. 111–120, 2006. View at Publisher · View at Google Scholar
  80. P. Vento, H. Mustonen, T. Joensuu, P. Kärkkäinen, E. Kivilaakso, and T. Kiviluoto, “Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer,” World Journal of Gastroenterology, vol. 13, no. 21, pp. 2945–2951, 2007.
  81. H. Golcher, T. Brunner, G. Grabenbauer, et al., “Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy,” European Journal of Surgical Oncology, vol. 34, no. 7, pp. 756–764, 2008. View at Publisher · View at Google Scholar · View at PubMed
  82. M. S. Talamonti, W. Small, Jr., M. F. Mulcahy, et al., “A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma,” Annals of Surgical Oncology, vol. 13, no. 2, pp. 150–158, 2006. View at Publisher · View at Google Scholar · View at PubMed
  83. W. Small, Jr., J. Berlin, G. M. Freedman, et al., “Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial,” Journal of Clinical Oncology, vol. 26, no. 6, pp. 942–947, 2008. View at Publisher · View at Google Scholar · View at PubMed
  84. J. Landry, P. Catalano, J. Hoffman, et al., “2111: ECOG 1200: a randomized phase II trial of gemcitabine plus radiotherapy vs gemcitabine, 5-fluorouracil and cisplatin followed by radiotherapy and 5-fluorouracil in patients with locally advanced, potentially resectable pancreatic adenocarcinoma,” International Journal of Radiation Oncology, Biology, Physics, vol. 66, no. 3, supplemnet, p. S272, 2006. View at Publisher · View at Google Scholar
  85. H. Yamaue, M. Tani, H. Onishi, et al., “Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection,” Pancreas, vol. 25, no. 4, pp. 366–372, 2002. View at Publisher · View at Google Scholar